These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
354 related articles for article (PubMed ID: 26463431)
1. A human papillomavirus (HPV)-16 or HPV-18 genotype is a reliable predictor of residual disease in a subsequent hysterectomy following a loop electrosurgical excision procedure for cervical intraepithelial neoplasia 3. Kang WD; Ju UC; Kim SM J Gynecol Oncol; 2016 Jan; 27(1):e2. PubMed ID: 26463431 [TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus genotyping as a reliable prognostic marker of recurrence after loop electrosurgical excision procedure for high-grade cervical intraepithelial neoplasia (CIN2-3) especially in postmenopausal women. Kang WD; Kim SM Menopause; 2016 Jan; 23(1):81-6. PubMed ID: 26057824 [TBL] [Abstract][Full Text] [Related]
3. Clinical predictors of residual disease in hysterectomy following a loop electrosurgical excision procedure for cervical intraepithelial neoplasia grade 3. Wu Q; Jiang Y; Ding J; Xia L; Xu H BMC Pregnancy Childbirth; 2022 Dec; 22(1):971. PubMed ID: 36575366 [TBL] [Abstract][Full Text] [Related]
4. Residual lesions in uterine specimens after loop electrosurgical excision procedure in patients with CIN. Jing L; Dan W; Zhunan L; Ying X; Yi C Arch Gynecol Obstet; 2018 Oct; 298(4):805-812. PubMed ID: 30167855 [TBL] [Abstract][Full Text] [Related]
5. Post-treatment human papillomavirus status and recurrence rates in patients treated with loop electrosurgical excision procedure conization for cervical intraepithelial neoplasia. Du R; Meng W; Chen ZF; Zhang Y; Chen SY; Ding Y Eur J Gynaecol Oncol; 2013; 34(6):548-51. PubMed ID: 24601049 [TBL] [Abstract][Full Text] [Related]
6. Risk factors predicting residual disease in subsequent hysterectomy following conization for cervical intraepithelial neoplasia (CIN) III and microinvasive cervical cancer. Park JY; Lee SM; Yoo CW; Kang S; Park SY; Seo SS Gynecol Oncol; 2007 Oct; 107(1):39-44. PubMed ID: 17582476 [TBL] [Abstract][Full Text] [Related]
7. Pap Smear Combined with HPV Testing: A Reasonable Tool for Women with High-grade Cervical Intraepithelial Neoplasia Treated by LEEP. Mo LZ; Song HL; Wang JL; He Q; Qiu ZC; Li F Asian Pac J Cancer Prev; 2015; 16(10):4297-302. PubMed ID: 26028089 [TBL] [Abstract][Full Text] [Related]
8. Pre- and post-conization high-risk HPV testing predicts residual/recurrent disease in patients treated for CIN 2-3. Alonso I; Torné A; Puig-Tintoré LM; Esteve R; Quinto L; Campo E; Pahisa J; Ordi J Gynecol Oncol; 2006 Nov; 103(2):631-6. PubMed ID: 16780934 [TBL] [Abstract][Full Text] [Related]
9. Significance of human papillomavirus genotyping with high-grade cervical intraepithelial neoplasia treated by a loop electrosurgical excision procedure. Kang WD; Oh MJ; Kim SM; Nam JH; Park CS; Choi HS Am J Obstet Gynecol; 2010 Jul; 203(1):72.e1-6. PubMed ID: 20417477 [TBL] [Abstract][Full Text] [Related]
10. [Clinical outcome and high risk factor for residual lesion analysis of HSIL half a year after loop electrosurgical excision procedure: a clinical study of 1 502 cases]. Liu L; Chen LM; Tao X; Dai F; Guo LP; Zhang HW; Zhou XR; Sui L Zhonghua Fu Chan Ke Za Zhi; 2017 Nov; 52(11):751-756. PubMed ID: 29179270 [No Abstract] [Full Text] [Related]
11. [Early human papillomavirus testing predicts residual/recurrent disease after LEEP risk factors for predicting residual disease in high-grade squamous cervical intraepithelial neoplasia following LEEP conization]. Niu XY; Feng YK Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Mar; 46(2):321-5. PubMed ID: 25924452 [TBL] [Abstract][Full Text] [Related]
12. Residual and recurrent disease rates following LEEP treatment in high-grade cervical intraepithelial lesions. Baloglu A; Uysal D; Bezircioglu I; Bicer M; Inci A Arch Gynecol Obstet; 2010 Jul; 282(1):69-73. PubMed ID: 19940997 [TBL] [Abstract][Full Text] [Related]
13. Assessment of cervical intraepithelial neoplasia (CIN) with colposcopic biopsy and efficacy of loop electrosurgical excision procedure (LEEP). Duesing N; Schwarz J; Choschzick M; Jaenicke F; Gieseking F; Issa R; Mahner S; Woelber L Arch Gynecol Obstet; 2012 Dec; 286(6):1549-54. PubMed ID: 22865036 [TBL] [Abstract][Full Text] [Related]
14. Risk factors for residual lesions after total hysterectomy in patients with high-grade cervical intraepithelial neoplasia. Wang J; Wang C; Su T BMC Womens Health; 2024 Jun; 24(1):369. PubMed ID: 38915002 [TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus test after conization in predicting residual disease in subsequent hysterectomy specimens. Park JY; Kim DY; Kim JH; Kim YM; Kim YT; Nam JH Obstet Gynecol; 2009 Jul; 114(1):87-92. PubMed ID: 19546763 [TBL] [Abstract][Full Text] [Related]
16. Adjuvant VACcination against HPV in surgical treatment of Cervical Intra-epithelial Neoplasia (VACCIN study) a study protocol for a randomised controlled trial. van de Laar RLO; Hofhuis W; Duijnhoven RG; Polinder S; Melchers WJG; van Kemenade FJ; Bekkers RLM; Van Beekhuizen HJ BMC Cancer; 2020 Jun; 20(1):539. PubMed ID: 32517663 [TBL] [Abstract][Full Text] [Related]
17. Prediction of residual/recurrent disease by HPV genotype after loop excision procedure for high-grade cervical intraepithelial neoplasia with negative margins. Wu D; Zheng Y; Chen W; Guo C; Yu J; Chen G; Huang Y Aust N Z J Obstet Gynaecol; 2011 Apr; 51(2):114-8. PubMed ID: 21466511 [TBL] [Abstract][Full Text] [Related]
18. High-risk cervical epithelial neoplasia grade 1 treated by loop electrosurgical excision: follow-up and value of HPV testing. Alonso I; Torné A; Puig-Tintoré LM; Esteve R; Quinto L; Garcia S; Campo E; Pahisa J; Ordi J Am J Obstet Gynecol; 2007 Oct; 197(4):359.e1-6. PubMed ID: 17714678 [TBL] [Abstract][Full Text] [Related]
19. Analysis of Residual/Recurrent Disease and Its Risk Factors after Loop Electrosurgical Excision Procedure for High-Grade Cervical Intraepithelial Neoplasia. Wu J; Jia Y; Luo M; Duan Z Gynecol Obstet Invest; 2016; 81(4):296-301. PubMed ID: 26337009 [TBL] [Abstract][Full Text] [Related]
20. The performance of human papillomavirus DNA detection with type 16/18 genotyping by hybrid capture in primary test of cervical cancer screening: a cross-sectional study in 10,669 Chinese women. Zhao X; Wu Q; Wang X; Fu Y; Zhang X; Tian X; Cheng B; Lu B; Yu X; Lan S; Lu W; Ma D; Cheng X; Xie X Clin Microbiol Infect; 2018 Dec; 24(12):1322-1327. PubMed ID: 29518562 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]